Genelux (GNLX) Operating Expenses (2022 - 2026)
Genelux (GNLX) recorded quarterly Operating Expenses of $9.2 million in Q1 2026, down 2.64% quarter-over-quarter from $9.4 million in Q4 2025, and up 17.34% on a YoY basis from $7.8 million in Q1 2025.
Genelux (GNLX) Operating Expenses (2022 - 2026) Analysis & Trends
Genelux's Operating Expenses history runs 5 years deep, the most recent figure standing at $9.2 million for Q1 2026.
- In Q1 2026, Operating Expenses rose 17.34% year-over-year to $9.2 million; the TTM figure through Mar 2026 stood at $34.6 million (up 10.13% YoY), while the FY2025 annual figure was $33.2 million, up 4.79% from the prior year.
- Operating Expenses was $9.2 million for Q1 2026 at Genelux, down from $9.4 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $9.7 million in Q4 2024 to a low of $3.2 million in Q4 2022.
- Historically, Operating Expenses has averaged $7.1 million across 5 years, with a median of $7.0 million in 2023.
- The sharpest annual moves came in 2023 and 2025: Operating Expenses soared 121.41% in 2023, then retreated 3.78% in 2025.
- A 5-year view of Operating Expenses shows it stood at $3.2 million in 2022, then surged by 121.41% to $7.0 million in 2023, then surged by 39.24% to $9.7 million in 2024, then dropped by 3.36% to $9.4 million in 2025, then decreased by 2.64% to $9.2 million in 2026.
- The last three Operating Expenses figures came in at $9.2 million (Q1 2026), $9.4 million (Q4 2025), and $8.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.33 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -138.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 574,669.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.85 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -67.40 Mn |
| 10 | Genelux | 129.36 Mn | 129.36 Mn | - | 9.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.17 Mn |
| Dec 31, 2025 | 9.42 Mn |
| Sep 30, 2025 | 8.19 Mn |
| Jun 30, 2025 | 7.79 Mn |
| Mar 31, 2025 | 7.82 Mn |
| Dec 31, 2024 | 9.75 Mn |
| Sep 30, 2024 | 6.94 Mn |
| Jun 30, 2024 | 6.89 Mn |
| Mar 31, 2024 | 8.12 Mn |
| Dec 31, 2023 | 7.00 Mn |
| Sep 30, 2023 | 5.31 Mn |
| Jun 30, 2023 | 5.40 Mn |
| Mar 31, 2023 | 6.63 Mn |
| Dec 31, 2022 | 3.16 Mn |
| Sep 30, 2022 | 4.66 Mn |